Insider Trading June 8, 2026 05:07 PM

FirstCash Executive Raul Ramos Offloads $1.54M in Shares Amid Strong Q1 Performance

SVP of Latin American Operations sells 6,835 shares at $225.23 as company reports earnings that beat consensus estimates and raises sentiment with analyst upgrades.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
FCFS

FirstCash Holdings, Inc. (NASDAQ:FCFS) Senior Vice President of Latin American Operations, Raul Ramos, executed a significant stock sale on June 5, 2026, divesting 6,835 shares valued at approximately $1.54 million. This transaction occurs against a backdrop of robust corporate performance, with FirstCash recently reporting first-quarter results that exceeded Wall Street expectations across revenue, adjusted earnings per share, and adjusted EBITDA. The company's stock has demonstrated considerable momentum, trading near its 52-week high following an 81% gain over the past year. Despite this positive corporate trajectory, some analytical perspectives suggest the stock may be trading at elevated valuation multiples relative to current earnings.

FirstCash Executive Raul Ramos Offloads $1.54M in Shares Amid Strong Q1 Performance
FCFS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Raul Ramos, SVP of Latin American Operations at FirstCash Holdings, sold 6,835 shares at $225.23 per share, totaling $1,539,447 on June 5, 2026.
  • FirstCash reported strong Q1 financials, with revenue of $1.052 billion, adjusted EPS of $2.69, and adjusted EBITDA of $211 million, all exceeding analyst estimates.
  • Analysts Jefferies and Texas Capital Securities have raised price targets to $250 and $245 respectively, maintaining Buy ratings following the earnings beat.

Raul Ramos, serving as the Senior Vice President of Latin American Operations at FirstCash Holdings, Inc. (NASDAQ:FCFS), completed a notable divestment of company equity on June 5, 2026. The transaction involved the sale of 6,835 shares of FirstCash common stock, executed at a per-share price of $225.23. The aggregate value of this sale reached $1,539,447. This move by a key executive occurs while the broader market evaluates the company's recent financial trajectory and current valuation metrics.

Following the execution of this sale, Mr. Ramos retains a direct ownership position of 20,400 shares in FirstCash Holdings. His indirect holdings, managed through a 401(k) Plan, account for an additional 3,448 shares. The timing of the sale is particularly notable given the stock's recent price action. FirstCash shares have been trading near a 52-week high of $236. Over the trailing twelve-month period, the stock has appreciated by 81%. At the time of the transaction, the share price stood at $223.74, contributing to a total market capitalization for the company of $9.82 billion. Market analysis indicates that the stock appears to be trading at a premium, with a price-to-earnings ratio of 28.23, suggesting that shares are overvalued at current levels.

The executive transaction took place during a period of strong fundamental performance for FirstCash Holdings. The company recently reported first-quarter financial results that surpassed consensus analyst expectations. Revenue for the quarter reached $1.052 billion, exceeding the consensus estimate of $1.003 billion. Adjusted earnings per share were reported at $2.69, a figure significantly higher than the anticipated $2.33. Furthermore, the company's adjusted EBITDA came in at $211 million, surpassing the expected $196 million. These results reflect strong momentum across all of FirstCash's operating regions.

In response to the positive financial data, analyst sentiment has shifted positively. Both Jefferies and Texas Capital Securities have raised their price targets for FirstCash. Jefferies increased its target to $250, while Texas Capital raised its target to $245. Both firms maintained a Buy rating on the stock. Additionally, FirstCash announced a $600 million senior notes offering facilitated through its subsidiary. This debt issuance will be guaranteed by the parent company and its domestic subsidiaries, further indicating the company's active financial management and confidence in its operational stability.

Risks

  • The stock currently trades at a P/E ratio of 28.23, which analysis suggests indicates the shares are overvalued at current levels, posing a valuation risk.
  • The company has announced a $600 million senior notes offering, which increases corporate leverage and requires effective management of debt obligations.

More from Insider Trading

HRT Financial Liquidates Remaining Aditxt Holdings Following Sharp Stock Decline Jun 8, 2026 Glenbrook Capital Management Acquires Additional SenesTech Shares Amidst Strategic Shifts Jun 8, 2026 USANA Health Sciences Chief People Officer Liquidates Full Shareholding Jun 8, 2026 Werewolf Therapeutics Director Luke Evnin Offloads Shares via Rule 10b5-1 Plan Jun 8, 2026 BridgeBio Pharma CEO Executes $5.4M Stock Sale Under Pre-Arranged Trading Plan Jun 8, 2026